Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: Relevance to local angiotensin II system

Journal of Gastroenterology

Volumn 45, Issue 8, 2010, Pages 821-830

  Suekane, Takehisa ^a   Ikura, Yoshihiro ^a   Watanabe, Kenji ^a   Arimoto, Junko ^a   Iwasa, Yoko ^a   Sugama, Yoshimi ^a   Kayo, Soichiro ^a   Sugioka, Kenichi ^a   Naruko, Takahiko ^b   Maeda, Kiyoshi ^a   Hirakawa, Kosei ^a   Arakawa, Tetsuo ^a   Ueda, Makiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Angiotensin II; Crohn's disease; Phenotype; Smooth muscle cell; Stricture

Indexed keywords

ANGIOTENSIN II; CHYMASE;

ADULT; AGED; ARTICLE; CELL MOTION; CELL PROLIFERATION; CROHN DISEASE; FEMALE; HUMAN; INTESTINE MUCOSA; MALE; MAST CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; SMOOTH MUSCLE FIBER; STENOSIS, OCCLUSION AND OBSTRUCTION;

ADULT; AGED; ANGIOTENSIN II; CELL MOVEMENT; CELL PROLIFERATION; CHYMASES; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MAST CELLS; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE;

EID: 79952026537     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0232-6     Document Type: Article

References (49)

1. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis. 2004;10:55-60. (Pubitemid 38072447)
2. Graham MF. Pathogenesis of intestinal strictures in Crohn's disease - an update. Inflamm Bowel Dis. 1995;1:220-7.
3. Burke JP, Mulsow JJ, O'Keane C, Docherty NG, Watson RW, O'Connell PR. Fibrogenesis in Crohn's disease. Am J Gastroenterol. 2007;102:439-48. (Pubitemid 46160558)
4. Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn's disease. Hepatogastroenterology. 1990;37:18-31. (Pubitemid 20092204)
5. Kelly JK, Siu TO. The strictures, sinuses, and fissures of Crohn's disease. J Clin Gastroenterol. 1986;8:594-8. (Pubitemid 17180568)
6. Koukoulis G, Ke Y, Henley JD, Cummings OW. Obliterative muscularization of the small bowel submucosa in Crohn disease: a possible mechanism of small bowel obstruction. Arch Pathol Lab Med. 2001;125:1331-4. (Pubitemid 32976756)
7. Pucilowska JB, Williams KL, Lund PK. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol. 2000;279:G653-9.
8. Gelbmann CM, Mestermann S, Gross V, Köllinger M, Schölmerich J, Falk W. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut. 1999;45:210-7. (Pubitemid 29333769)
9. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033-79. (Pubitemid 27459579)
10. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest. 1991;88:493-9.
11. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem. 1997;272:7127-31. (Pubitemid 27166418)
12. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA. 1986;83:4464-8. (Pubitemid 16057069)
13. Ng KK, Vane JR. Fate of angiotensin I in the circulation. Nature. 1968;218:144-50.
14. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990;265:22348-57. (Pubitemid 120014308)
15. Ganong WF. Endocrine functions of the kidneys, heart, and pineal gland. In: Review of medical physiology. 20th ed. New York: McGraw-Hill; 2001, p. 439-451.
16. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-6.
17. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-6. (Pubitemid 21896571)
18. Inagami T, Kitami Y. Angiotensin II receptor: molecular cloning, functions, and regulation. Hypertens Res. 1994;17:87-97. (Pubitemid 24237159)
19. Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N, et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003;43:538-49. (Pubitemid 38002342)
20. Ikura Y, Ohsawa M, Shirai N, Sugama Y, Fukushima H, Suekane T, et al. Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Hepatol Res. 2005;32:107-16. (Pubitemid 40945770)
21. Gown AM, Vogel AM, Gordon D, Lu PL. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol. 1985;100:807-13. (Pubitemid 15135341)
22. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207. (Pubitemid 17183772)
23. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation. 1991;83:1327-32.
24. Ueda M, Becker AE, Naruko T, Kojima A. Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis. 1995;6:71-81.
25. Ohishi M, Ueda M, Rakugi H, Okamura A, Naruko T, Becker AE, et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation. 1997;96:3328-37. (Pubitemid 27513402)
26. Rakugi H, Okamura A, Kamide K, Ohishi M, Sasamura H, Morishita R, et al. Recognition of tissue- and subtype-specific modulation of angiotensin II receptors using antibodies against AT1 and AT2 receptors. Hypertens Res. 1997;20:51-5.
27. Takada Y, Unno M, Hiwada K, Kokubu T. Immunological and immunofluorescent studies of human angiotensin-converting enzyme. Clin Sci Lond. 1981;61(Suppl 7):253s-6s. (Pubitemid 12222743)
28. van der Loos CM, Becker AE, van den Oord JJ. Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J. 1993;25:1-13. (Pubitemid 23071782)
29. Dvorak AM, Osage JE, Monahan RA, Dickersin GR. Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol. 1980;11:620-34. (Pubitemid 11210405)
30. Graham MF, Drucker DE, Diegelmann RF, Elson CO. Collagen synthesis by human intestinal smooth muscle cells in culture. Gastroenterology. 1987;92:400-5. (Pubitemid 17231720)
31. Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology. 1988;94:257-65. (Pubitemid 18054760)
32. Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmermann EM, Sartor RB, et al. IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1307-22.
33. Groma V, Marcussen N, Olsen S. A quantitative immunohistochemical study of the expression of mesangial alpha-smooth muscle actin and the proliferation marker Ki-67 in glomerulonephritis in man. Virchows Arch. 1997;431:345-50. (Pubitemid 27487530)
34. Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol. 1991;138:1233-42.
35. Connell ND, Rheinwald JG. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell. 1983;34:245-53. (Pubitemid 13045474)
36. Van Muijen GN, Ruiter DJ, Warnaar SO. Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest. 1987;57:359-69.
37. Takahashi K, Jones PM, Kanse SM, Lam HC, Spokes RA, Ghatei MA, et al. Endothelin in the gastrointestinal tract. Presence of endothelinlike immunoreactivity, endothelin-1 messenger RNA, endothelin receptors, and pharmacological effect. Gastroenterology. 1990;99:1660-7.
38. Khan H, Naylor RJ, Tuladhar BR. Pharmacological characterization of endothelin receptors-mediated contraction in the mouse isolated proximal and distal colon. Br J Pharmacol. 2006;147:607-11.
39. Ehrlich HP, Allison GM, Page MJ, Kolton WA, Graham M. Increased gelsolin expression and retarded collagen lattice contraction with smooth muscle cells from Crohn's diseased intestine. J Cell Physiol. 2000;182:303-9. (Pubitemid 30022684)
40. Regan MC, Flavin BM, Fitzpatrick JM, O'Connell PR. Stricture formation in Crohn's disease: the role of intestinal fibroblasts. Ann Surg. 2000;231:46-50. (Pubitemid 30043938)
41. Hiatt RB, Katz L. Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol. 1962;37:541-5.
42. Yamada M, Ueda M, Naruko T, Tanabe S, Han YS, Ikura Y, et al. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int. 2001;59:1374-81. (Pubitemid 32281225)
43. Mitani Y, Ueda M, Maruyama K, Shimpo H, Kojima A, Matsumura M, et al. Mast cell chymase in pulmonary hypertension. Thorax. 1999;54:88-90. (Pubitemid 29103760)
44. Ohishi M, Ueda M, Rakugi H, Naruko T, Kojima A, Okamura A, et al. Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions. J Hypertens. 1999;17:547-53. (Pubitemid 29308565)
45. Jaszewski R, Tolia V, Ehrinpreis MN, Bodzin JH, Peleman RR, Korlipara R, et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis. Gastroenterology. 1990;98:1543-8. (Pubitemid 20158619)
46. Wengrower D, Zanninelli G, Pappo O, Latella G, Sestieri M, Villanova A, et al. Prevention of fibrosis in experimental colitis by captopril: the role of TGF-beta1. Inflamm Bowel Dis. 2004;10:536-45. (Pubitemid 39276460)
47. Jahovic N, Ercan F, Gedik N, Yüksel M, Sener G, Alican I. The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats. Regul Pept. 2005;130:67-74. (Pubitemid 40966024)
48. Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S. Amelioration of 2, 4, 6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut. 2005;54:349-56. (Pubitemid 40299090)
49. Hume GE, Fowler EV, Lincoln D, Eri R, Templeton D, Florin TH, et al. Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease. J Med Genet 2006;43:e51.